Vicus Capital Amgen Inc Transaction History

Vicus Capital

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $338,924 - $376,012	-1,451 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $25,741 - $29,997	116 Added 8.69%	1,451 $361,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $37,433 - $44,576	173 Added 14.89%	1,335 $307,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $72,506 - $80,633	309 Added 36.23%	1,162 $295,000
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $168,731 - $207,057	853 New	853 $201,000
Q3 2019 Nov 18, 2019	SELL	$174.11 - $208.62 $226,865 - $271,831	-1,303 Closed	0 $0
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $333 - $390	-2 Reduced 0.15%	1,303 $240,000
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $38,525 - $43,426	-213 Reduced 14.03%	1,305 $248,000
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $37,999 - $44,357	213 Added 16.32%	1,518 $295,000
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $16,676 - $18,800	-90 Reduced 6.45%	1,305 $270,000
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $4,483 - $5,035	-27 Reduced 1.9%	1,395 $257,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $15,756 - $18,414	-93 Reduced 6.14%	1,422 $242,000
Q4 2017 Jan 25, 2018	SELL	$168.79 - $188.59 $106,506 - $119,000	-631 Reduced 29.4%	1,515 $263,000
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $359,004 - $409,886	2,146	2,146 $400,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Vicus Capital, based on Form 13F filings with the SEC.

Stay updated on Vicus Capital with notifications on news.